Overview

Acne is a chronic inflammatory disease of the pilosebaceous unit resulting from androgen-induced increased sebum production, altered keratinization, inflammation, and bacterial colonization of hair follicles on the face, neck, chest, and back by, Cutibacterium acnes. Although all age groups can be affected, it is primarily a disease of adolescence. Treatment selection is based on disease severity, patient preference, and tolerability. Isotretinoin is drug of chioce used for moderate and severe acne. Isotretinoin results in a significant reduction in sebum production, influences comedogenesis, lowers surface and ductal c. acnes and has anti-inflammatory properties. Biotin deficiency may be caused by insufficient dietary uptake of biotin, drug- vitamin interactions and increased biotin catabolism during pregnancy and in smokers. Biotin deficiency can also be precipitated by decreased activities of biotinidase, which plays a central role in the intestinal absorption of biotin

Eligibility

Inclusion Criteria:

        Age of 19 to 35 years. Body mass index (BMI) of 18.5 to 23 kg/m2. Acne vulgaris (global
        acne scoring more than 18)
        Exclusion Criteria:
        Use of oral steroids, oral contraceptives, oral vitamin A derivatives, antibiotics, or
        herbal medicines that may affect the test results during the last 4 weeks.
        Alcohol drinking within the last week. Smoking. Pregnancy or lactation. Judgement that
        physical or mental testing is not appropriate for the clinical trial.
        Participation in other clinical trials that may affect this t